旧貌换新颜

Kyleen E. Davis
{"title":"旧貌换新颜","authors":"Kyleen E. Davis","doi":"10.1097/jdn.0000000000000786","DOIUrl":null,"url":null,"abstract":"\n In recent years, multiple novel and improved therapies have become available to treat alopecia disorders. Whereas many therapeutics are entirely new, some medications, such as oral minoxidil, have been available for years and are just now being revisited as potentially valuable hair loss treatments. This article discusses the risks, benefits, and potential side effects of the off-label use of low-dose oral minoxidil. It compares low-dose oral minoxidil with topical minoxidil, a well-established and FDA-approved treatment for androgenetic alopecia, but one that is often associated with poor overall adherence. Finally, nursing considerations in the education and care of patients with alopecia disorders and associated medications are discussed.","PeriodicalId":17315,"journal":{"name":"Journal of the Dermatology Nurses' Association","volume":null,"pages":null},"PeriodicalIF":0.2000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"What's Old Is New Again\",\"authors\":\"Kyleen E. Davis\",\"doi\":\"10.1097/jdn.0000000000000786\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\\n In recent years, multiple novel and improved therapies have become available to treat alopecia disorders. Whereas many therapeutics are entirely new, some medications, such as oral minoxidil, have been available for years and are just now being revisited as potentially valuable hair loss treatments. This article discusses the risks, benefits, and potential side effects of the off-label use of low-dose oral minoxidil. It compares low-dose oral minoxidil with topical minoxidil, a well-established and FDA-approved treatment for androgenetic alopecia, but one that is often associated with poor overall adherence. Finally, nursing considerations in the education and care of patients with alopecia disorders and associated medications are discussed.\",\"PeriodicalId\":17315,\"journal\":{\"name\":\"Journal of the Dermatology Nurses' Association\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.2000,\"publicationDate\":\"2024-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of the Dermatology Nurses' Association\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1097/jdn.0000000000000786\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"DERMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the Dermatology Nurses' Association","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/jdn.0000000000000786","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"DERMATOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

近年来,治疗脱发疾病的新疗法层出不穷。虽然许多疗法都是全新的,但有些药物(如口服米诺地尔)已问世多年,现在才作为有潜在价值的脱发治疗方法被重新审视。本文讨论了标签外使用低剂量口服米诺地尔的风险、益处和潜在副作用。文章将低剂量口服米诺地尔与外用米诺地尔进行了比较,外用米诺地尔是美国食品及药物管理局批准的治疗雄激素性脱发的成熟疗法,但其总体依从性往往较差。最后,还讨论了教育和护理脱发症患者及相关药物的护理注意事项。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
What's Old Is New Again
In recent years, multiple novel and improved therapies have become available to treat alopecia disorders. Whereas many therapeutics are entirely new, some medications, such as oral minoxidil, have been available for years and are just now being revisited as potentially valuable hair loss treatments. This article discusses the risks, benefits, and potential side effects of the off-label use of low-dose oral minoxidil. It compares low-dose oral minoxidil with topical minoxidil, a well-established and FDA-approved treatment for androgenetic alopecia, but one that is often associated with poor overall adherence. Finally, nursing considerations in the education and care of patients with alopecia disorders and associated medications are discussed.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
0.30
自引率
25.00%
发文量
45
期刊最新文献
Registration, Voting, and the Dermatology Nurse Skin Barrier Function of Black African and White Nursing Students Keratoacanthoma Treatment Options Your Voice, Your Vote—Your Superpower Awareness of Skin Cancer in the Prospective Epidemiological Research Studies in Iran Guilan Cohort Study Population
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1